Optical Sensors acquires technology, renamed Vasamed:
This article was originally published in Clinica
Minneapolis, Minnesota-based haemodynamic monitoring technology firm Optical Sensors has changed its name to Vasamed. The new name "better reflects the suite of products that we currently have and will be introducing for haemodynamic monitoring", said president and CEO Paulita LaPlante. The company, which developed the CapnoProbe sensor system to measure sublingual CO(2), has also acquired from an unnamed private company an FDA-cleared impedance cardiography system for noninvasive cardiac output monitoring. It intends to refine the software and other features and launch the product in the next few months.